Evidence map›Paper›PMID 40540706›Full record

ArticleJCO oncology practice2026

Transitions Within and Use of Outpatient Primary and Oncology Care in Survivors of Adolescent and Young Adult-Onset Cancers.

Erin E Hahn, Eric C Haupt, Neetu Chawla, Thearis A Osuji, Ernest Shen, Andrew B Smitherman, Mallory Casperson, Anne C Kirchhoff, Bradley J Zebrack, Cecile A Laurent and 6 more

Abstract read
In one paragraph

Article in JCO oncology practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Erin E HahnKaiser Permanente Southern California Department of Research and Evaluation, Pasadena, CA.ORCID 0000-0002-8419-2331
Eric C HauptKaiser Permanente Southern California Department of Research and Evaluation, Pasadena, CA.ORCID 0000-0001-8099-2801
Neetu ChawlaVeteran's Affairs Los Angeles County, Los Angeles, CA.ORCID 0000-0003-3486-2023
Thearis A OsujiKaiser Permanente Southern California Department of Research and Evaluation, Pasadena, CA.
Ernest ShenKaiser Permanente Southern California Department of Research and Evaluation, Pasadena, CA.
Andrew B SmithermanLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, Chapel Hill, NC.
Mallory CaspersonCactus Cancer Society, Oakland, CA.
Anne C KirchhoffDepartment of Pediatrics, Huntsman Cancer Institute and the University of Utah, Salt Lake City, UT.ORCID 0000-0002-0747-9179
Bradley J ZebrackSchool of Social Work, University of Michigan, Ann Arbor, MI.ORCID 0000-0001-7026-1984
Cecile A LaurentDivision of Research, Kaiser Permanente Northern California, Pleasanton, CA.ORCID 0000-0001-9332-6971
Theresa H M KeeganDivision of Hematology and Oncology, Center for Oncology Hematology Outcomes Research and Training (COHORT), University of California Davis Comprehensive Cancer Center, Sacramento, CA.ORCID 0000-0002-1961-4008
Renata AbrahãoDivision of Hematology and Oncology, Center for Oncology Hematology Outcomes Research and Training (COHORT), University of California Davis Comprehensive Cancer Center, Sacramento, CA.ORCID 0000-0002-1644-0313
Kathryn J RuddyDivision of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN.ORCID 0000-0001-6298-332X
Jessica ChubakKaiser Permanente Washington Health Research Institute, Seattle, WA.ORCID 0000-0003-1630-9021
Hazel B NicholsLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, Chapel Hill, NC.ORCID 0000-0003-0972-1560
Karen J WernliDepartment of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA.ORCID 0000-0001-7945-0327

Funding

Project 3: Chronic Medical Conditions and Late Effects in the AYA Cancer PopulationP01CA233432 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI CHUBAK, JESSICA, HAHN, ERIN ELIZABETH · 2020 to 2025
$10.5M
NCI NIH HHS P01 CA233432
6 · The paper itself

Abstract

purposeSurvivors of adolescent and young adult (AYA)-onset cancers require comprehensive cancer surveillance care. Guidelines recommend 1-4 clinician visits annually for 5 years depending on stage and disease. The goal of this study was to identify factors associated with patterns of post-treatment primary and oncology care in a large cohort of survivors of AYA-onset cancers diagnosed within an integrated health care system.

methodsPatients diagnosed with cancer between 2006 and 2020 age 15-39 years were included. Surveillance visits were identified from electronic medical records 2-5 years after diagnosis. Multivariable logistic regression was used to assess associations with zero oncology specialty visits.

resultsOf 7,925 survivors, 46% were Hispanic, 6% non-Hispanic Black, 11% non-Hispanic Asian, 35% non-Hispanic White, and 65% female. One-quarter had no oncology specialty visits in the first surveillance year rising to 38% in year 5; 31% had 3+ visits in the first year, declining to 13% in year 5. Over the surveillance period, 17% did not have any oncology specialty visits and 6% had no primary care or oncology visits. Those who were male (odds ratio [OR], 1.21 [95% CI, 1.02 to 1.45]), 20-24 years at diagnosis (OR, 1.58, 95% CI, 1.27 to 1.9;

conclusionAlthough the majority of this cohort received either primary or oncology specialty care, our study identifies those who may need tailored outreach for follow-up care. Continued research into development and testing of interventions to improve uptake of appropriate health care for survivors of AYA-onset cancers is critical.

Indexed as

Ambulatory CareCancer SurvivorsMedical OncologyNeoplasmsPrimary Health CareAdolescentAdultFemaleHumansMaleYoung Adult

Identifiers

PMID40540706
PMCPMC12354005

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.